New policy aims to standardise screening, diagnosis and lifelong care for children with diabetes across India’s public health system
Compared to a net loss of Rs 12 crore in FY25, the pharma major reported a consolidated turnaround in its financial performance
Our company remains focused on advancing monoclonal antibody therapeutics for solid tumors, with a clear emphasis on combination immunotherapy strategies
New acetabular system enhances precision, stability and robotic compatibility in total hip arthroplasty
_256_384.png){kind=logo}
New plan integrates critical illness protection, market-linked health fund and preventive care platform for holistic financial and health security
India leads the shift as wellness tourism integrates healthcare, hospitality, and lifestyle
The summit brought together over 150 doctors, researchers, and practitioners worldwide
The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before
The acquisition brings three established small-molecule drug substance facilities into Siegfried’s global network
Shares issued under ESOP 2008 and MESOP 2018 plans following exercise of vested stock options, in compliance with SEBI disclosure norms
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
